CCDS-O Sample Questions Answers

The CMS-HCC model is arisk adjustmentmethodology used primarily to setcapitated paymentsfor Medicare Advantage (MA) organizations based on the expected cost of caring for their enrolled beneficiaries. Under this approach, CMS calculates a Risk Adjustment Factor (RAF) for each member using demographic variables (such as age/sex and certain entitlement factors) plus disease burden captured from ICD-10-CM diagnoses that map to Hierarchical Condition Categories (HCCs). The resulting RAF increases or decreases the plan’s payment to better match predicted healthcare needs—higher RAF for sicker, more complex patients and lower RAF for healthier patients. ACDIS outpatient CDI education emphasizes that the purpose is not physician reimbursement based on a “principal diagnosis” (an inpatient concept) and not payment distribution tied directly to quality performance (that aligns more with MIPS/VBP frameworks). It also does not adjust capitation payments specifically “to physicians,” nor does it exclude advanced practice providers in the way described. The correct use is todetermine MA plan capitation paymentsthrough risk-adjusted member-level projections.

In stage 3 chronic kidney disease, impaired vitamin D activation and early disturbances in calcium-phosphate regulation commonly drive a compensatory rise in parathyroid hormone (PTH), known as secondary hyperparathyroidism of renal origin. Outpatient CDI chart review looks for clinical indicators that suggest a condition being evaluated or requiring management, and an elevated iPTH in a CKD patient is a classic indicator that supports querying the provider for CKD-related mineral and bone disorder, specifically renal secondary hyperparathyroidism, if it is clinically being assessed/treated (e.g., monitoring trends, prescribing vitamin D analogs, calcimimetics, dietary counseling, nephrology follow-up). Primary hyperparathyroidism is less supported here because it typically requires a different biochemical pattern and clinical context (often hypercalcemia) rather than being driven by CKD physiology. Hypoparathyroidism is the opposite process (low PTH), making option C inconsistent with the lab finding. Option D is not supported because phosphorus is normal, not low, and hypophosphatemia is not documented as a driver. Therefore, querying for renal secondary hyperparathyroidism is most appropriate.

For outpatient E/M reporting, “new vs. established patient” status is determined using a lookback period based on prior professional services. Anestablished patientis one who has received face-to-face (or other qualifying professional) services from the same physician or another physician/qualified healthcare professional of thesame specialty and subspecialtyin thesame group practicewithin theprevious three years. This definition is critical for compliant coding because it drives which E/M code family is available (new patient codes vs established patient codes), and it affects relative valuation, documentation expectations, and audit risk. Outpatient CDI education emphasizes helping providers document the medical necessity and complexity of the visit regardless of patient status, but also ensuring correct administrative classification so coders select the correct code set. The three-year window prevents inappropriate use of new patient codes when the patient has an ongoing clinical relationship with the practice/specialty, supporting accurate reimbursement and consistent reporting.

Under Medicare billing rules applied in outpatient CDI education,observation services are outpatient(typically paid under Part B), even though the patient may stay in a hospital bed and receive ongoing monitoring and treatment. Therefore, anED visit that converts to observationremains an outpatient encounter from a billing and documentation perspective, and the services are reported/paid as outpatient. By contrast, when an ED visit results in aninpatient admission, the encounter transitions to inpatient status, and many hospital ED services immediately preceding admission are commonly bundled/packaged with the inpatient stay rather than billed as a separate outpatient encounter. A scheduledsigmoid resectionis generally a major procedure that is not typically performed as ambulatory/outpatient surgery in routine circumstances, so it is not the best outpatient choice here. Finally, “admission for COPD exacerbation with LOS less than two midnights” is ambiguous because “admission” implies inpatient, even though short stays may sometimes be observation/outpatient depending on medical necessity and the 2-midnight guidance. The clearest outpatient encounter is ED leading to observation.

Outpatient CDI queries are most commonly triggered when there is a disconnect between the documented diagnosis and the documented treatment plan, suggesting that the clinician may be managing an additional condition that is not clearly stated, or that the diagnosis is inaccurately documented. Options A and B reflect typical, clinically aligned management: luteinizing hormone-releasing hormone therapy is a standard treatment pathway for prostate carcinoma, and amiodarone is a recognized antiarrhythmic used in atrial fibrillation management in appropriate circumstances. Option C can also be clinically consistent because parenteral nutrition is often used when malnutrition is present and the patient cannot meet nutritional needs enterally. Option D is the outlier: “immunotherapy” is not a standard treatment for severe major depressive disorder and more commonly aligns with oncology or certain immune-mediated diseases. This mismatch would appropriately prompt a query to clarify the actual condition being treated (e.g., an active malignancy) or to confirm whether “immunotherapy” refers to something else (such as allergy immunotherapy) and whether depression is the correct, visit-relevant diagnosis being addressed.

Beta-blockers are commonly used in the management of coronary artery disease (CAD) because they lower heart rate, decrease myocardial contractility, and reduce oxygen demand—key goals in treating stable angina and in secondary prevention after myocardial infarction. In outpatient chart review, ACDIS-focused clinical documentation education emphasizes linking the medication to the condition being managed (e.g., “CAD with angina—on metoprolol for symptom control” or “history of MI—on beta-blocker for secondary prevention”) to support accurate diagnosis reporting and demonstrate ongoing assessment and treatment. By contrast, third-degree (complete) heart block and sinus bradycardia are conditions where beta-blockers are typically avoided or used only with extreme caution because they can worsen conduction delay and slow the heart rate further. Cardiomyopathy can sometimes be treated with certain evidence-based beta-blockers when the clinical context is systolic heart failure, but the option most broadly and reliably associated with beta-blocker treatment in standard outpatient practice and documentation is CAD.

Symbicort is an inhaled combination medication containing an inhaled corticosteroid (ICS) and a long-acting beta-agonist (LABA). In outpatient chart review, this medication class is most strongly associated with chronic airway inflammatory diseases requiring controller therapy—especiallypersistent asthma(and also maintenance therapy for COPD, though COPD is not an option here). For CDI purposes, medication-to-diagnosis linkage can act as a clinical indicator supporting clarification when the visit note lists respiratory symptoms but does not clearly document the chronic condition being treated or its acuity/status. Symbicort is not used to treat musculoskeletal degenerative disease (osteoarthritis), peripheral nerve pain from diabetes (diabetic neuropathy), or cardiac pump failure (congestive heart failure). When Symbicort appears on the active med list, outpatient CDI commonly checks that the provider’s documentation appropriately reflects asthma classification (intermittent vs persistent), current control, exacerbation status if applicable, and that the condition is being monitored/assessed/treated during the encounter to support reportability and accurate coding.

In the outpatient setting, thefirst-listed diagnosisis the condition chiefly responsible for the services provided during the encounter. Here, the stated reason for the visit iscontinued confusion and poor memory, and the provider specifically evaluates the patient’scurrent mental stateand references neurology consultation notes—actions that directly support assessment of a cognitive disorder. While HTN, GERD, and Parkinson’s are also addressed and may be reportable if they meet encounter relevance (e.g., monitored, evaluated, assessed/managed, or treated), they are not the primary driver for today’s visit based on the presenting complaint. Outpatient documentation and coding guidance emphasizes sequencing the diagnosis that best explains the visit’s main purpose first, with additional coexisting conditions listed afterward when they impact care. Since “dementia” is on the active problem list and aligns with the patient’s cognitive symptoms and the physician’s mental-status evaluation, it is the most appropriate first-listed diagnosis among the options.

RAF (Risk Adjustment Factor) is best explained to providers as a population-health and resource-planning tool, not a visit-level payment lever. In outpatient risk adjustment models, diagnoses and demographics are used to estimate the patient’s overall disease burden and the expected cost/resources required to meet that patient’s healthcare needs. When documentation accurately reflects active conditions and their specificity, the patient’s risk profile is represented more realistically. That improves care in practical ways: it supports appropriate allocation of care management services (e.g., nurse navigators, chronic care programs), helps organizations anticipate medication, testing, specialist, and follow-up needs, and improves fairness of performance benchmarking by comparing outcomes and costs against similarly complex patients. Option A is overly simplistic because RAF does not directly determine an individual provider’s reimbursement for a given encounter; it influences broader payment and benchmarking methodologies tied to attributed populations. Option C is not what RAF measures, and option D confuses RAF with medical necessity, which is based on clinical documentation and coverage rules, not a risk score.

RADV (Risk Adjustment Data Validation) is a CMS audit program used in Medicare Advantage to confirm that diagnoses submitted for risk adjustment are supported by medical record documentation and meet reporting requirements. Its central aim ispayment integrity—ensuring that risk-adjusted capitation payments to Medicare Advantage organizations are accurate based on valid, documented conditions. In outpatient CDI practice, RADV risk underscores why documentation must clearly support each reported diagnosis (e.g., condition evaluated/assessed/treated, clinically relevant, and properly documented by an eligible provider), because unsupported diagnoses can lead to payment recoupment and compliance exposure. RADV is not designed to assess medical necessity of the services provided (that is typically addressed through utilization review and other payer audits), nor is it focused on identifying overpayments to individual physicians (it targets plan-level risk adjustment payments). It also is separate from E/M leveling accuracy, which is governed by CPT/E/M guidelines and distinct audit processes. Therefore, the best definition of RADV’s primary purpose is ensuring the integrity and accuracy of risk-adjusted payments.

In outpatient CDI and coding education, selecting the correct E/M code starts with identifying theencounter category(e.g., office/outpatient vs inpatient/observation vs ED) and whether the patient isnew or established, because these define the applicable CPT code range. Next, thelevel of serviceis selected within that range based on the documentation supporting the required elements for that code family. For most E/M services, “site of service” (place/setting) and “new vs established” are foundational code-selection drivers, while “level” is determined by the record’s support for the applicable leveling methodology (commonly medical decision making and, when allowed/appropriate, time). Time can be a valid leveling method for many office/outpatient E/M visits, but it is not universally the basis for the majority of E/M services across all categories; it is an alternative pathway when documentation supports it. Physician specialty and patient age do not define the majority of E/M code selection. Therefore, the best overall statement is new/established status + site of service + level of service.

The only conclusion that is directly supported by the table is that Clinic A’spercent RAF captured is higher in every month of 2023 compared with the corresponding month in 2022. The monthly values rise year-over-year (e.g., January 21% vs 17%, February 33% vs 25%, and continuing through December 84% vs 76%), showing a consistent improvement pattern across the entire calendar year. In outpatient CDI and risk adjustment work, “RAF capture” is commonly used as a performance indicator reflecting how completely documented and coded risk-adjusting conditions (e.g., HCC-supported diagnoses) are being captured within the measurement period. However, the tabledoes notprove why the improvement occurred. It cannot confirm provider engagement (A) without workflow/participation data, cannot compare to other clinics (B) because no other clinic data are shown, and cannot establish that the population was sicker (C) because RAF capture measures documentation/coding completeness relative to opportunity, not inherent patient acuity. Therefore, D is the verified conclusion.

Pulmonary rales (crackles), radiographic pulmonary edema, and peripheral (ankle) edema together strongly suggest a systemic volume overload state, most classically due to heart failure. In ambulatory CDI chart review, these findings function as clinical indicators that drive the provider’s diagnostic reasoning and typically prompt further evaluation of heart failure type and status (e.g., acute vs chronic, systolic vs diastolic, preserved vs reduced EF), along with assessment of severity and potential decompensation. Providers commonly correlate these indicators with additional data such as weight gain trends, BNP, echocardiogram findings, medication adherence (diuretics), and signs of congestion to determine whether the patient is experiencing a heart failure exacerbation requiring treatment adjustments. While pleural effusion may coexist and pneumonia can cause rales, the presence of pulmonary edema on chest x-ray plus bilateral ankle edema points more directly to a cardiac/volume etiology than an isolated infectious process. Pulmonary hypertension may contribute to dyspnea and edema but does not most directly explain pulmonary edema on imaging in the same way. Therefore, heart failure is the most likely condition to be evaluated further.

This question applies the outpatient risk adjustment “reserve” concept: predicted cost is estimated by multiplying the member’s risk factor contribution by a baseline per-member-per-month (PMPM) amount, then annualizing. The morbid obesity HCC factor is 0.186, and PMPM is $800. First compute the monthly cost impact: $800 × 0.186 = $148.80 per month per patient. Convert to yearly: $148.80 × 12 = $1,785.60 per patient per year. The year-over-year increase in patients with morbid obesity documentation is 11,000 − 10,000 = 1,000 additional patients. Multiply the annual per-patient impact by the additional patient count: $1,785.60 × 1,000 = $1,785,600. Outpatient CDI programs emphasize that improving documentation specificity (when clinically supported) can change whether an HCC is captured, which can affect RAF-based projections and resource planning. However, documentation must still be accurate, supported, and reflect conditions assessed/managed during the encounter.

A compliant prospective query is initiated before the next encounter so the provider can clarify documentation during the upcoming visit, using clinically relevant indicators without directing a specific diagnosis. Option A does this appropriately: it references an existing CHF history and a supportive medication (Lasix), then asks the provider to confirm whether CHF is pertinent at the next visit and, if so, to specify type and acuity. This supports accurate outpatient reporting because heart failure coding requires specificity (systolic/diastolic/combined; acute/chronic/acute on chronic) and should reflect what is actually evaluated/managed at the encounter. Option B is retrospective and attempts to justify a prior test. Option C is leading because it asks the provider to “add” a diagnosis to a past note rather than clarify current clinical status. Option D is also retrospective and uses “please add CHF,” which is leading and can be perceived as prompting. Therefore, A best demonstrates a compliant prospective query.

The most compliant query is the one that is clinically supported, non-leading, and focused on clarifying documentation for correct reporting and medical necessity—without directing the provider to “add” diagnoses or document conditions for payment purposes. Option A presents relevant clinical context (no GI symptoms; family history) and asks the provider to clarify whether the planned colonoscopy is screening or diagnostic, which is a legitimate documentation clarification affecting correct code selection and coverage rules. It does not imply a desired answer and does not instruct the provider to document additional diagnoses. Option B is problematic because it instructs the provider to “document these conditions” if treated, which can be perceived as prompting and is not tied to encounter-specific indicators. Option C is based primarily on historical information and asks a yes/no about remission, which can be leading and may not reflect current-visit evaluation. Option D effectively asks the provider to add a diagnosis based on nursing documentation, which risks leading language and requires provider confirmation and assessment. Therefore, A is most compliant.

In outpatient risk adjustment, the highest-impact clarification is often the one that determines whether a condition is currently active (and therefore risk-adjustable) versus historical/resolved. “Leukemia” listed on the problem list, plus active review of CBC/WBC and referral to oncology, strongly suggests ongoing disease evaluation/management. ACDIS outpatient CDI principles emphasize querying to confirm whether the leukemia is active, in relapse, or in remission because that distinction can change code selection from an active malignancy to a history code, and history codes typically do not carry the same risk adjustment impact as an active HCC-bearing diagnosis. While heart failure type/acuity and malnutrition severity are also important for specificity and may affect risk capture, they generally represent refinement of already-established chronic conditions rather than a potential “on/off” determination of a major disease category. Likewise, atrial fibrillation subtype differentiation is clinically useful but usually does not materially change risk adjustment compared with confirming an active hematologic malignancy. Therefore, clarifying leukemia status/acuity is the most impactful risk-adjusted query opportunity.

The HHS-HCC risk adjustment model (used for ACA Marketplace plans) calculates a member’s risk score using a combination ofdemographic factorsanddiagnosis codesthat map to HHS-HCCs. Among the listed health record elements,genderis a core demographic variable used in the model’s coefficients because expected healthcare utilization and cost patterns differ by age/sex groupings. In outpatient CDI terms, this is why accurate demographic data capture (including sex) matters alongside complete and specific condition reporting. CPT codes do not drive HHS-HCC risk scores; the model relies on diagnosis reporting (ICD-10-CM) rather than procedure codes for risk category assignment. Discharge status is an encounter/billing element relevant to certain facility payment and quality measures, but it is not a standard HHS-HCC risk score input. Ethnicity is not used as a direct risk adjustment variable in the HHS-HCC model for score calculation. Therefore, gender is the correct element that impacts HHS-HCC risk scores.

In the outpatient setting, when the provider does not document a definitive diagnosis for the acute complaint (e.g., influenza, sinusitis, URI), ICD-10-CM guidance directs coders to report thesigns and symptomsthat are documented and addressed. Here, the clinician documentscongestion, fever, and malaiseand provides treatment instructions for those symptoms (OTC meds, rest, follow-up). That makes the symptom codes the most appropriate representation of the reason for the encounter. Outpatient CDI principles further emphasize that chronic conditions likeDM, GERD, and HTNshould only be coded when the documentation shows they wereevaluated, monitored, assessed/managed, or treatedduring the visit (e.g., status, control, medication adjustment, related testing, counseling). In this note, the plan targets only the acute symptoms and does not demonstrate active management of the chronic conditions beyond listing history/medications. Therefore, the guideline most directly applicable to correct coding of the encounter iscodes that describe symptoms and signs.

Nightly reliance on CPAP in a morbidly obese patient most strongly points to sleep-disordered breathing, and in the context of severe obesity (BMI 45), it raises concern forobesity hypoventilation syndrome (OHS), which is characterized byalveolar hypoventilation(chronic hypoventilation with hypercapnia) that is not fully explained by other pulmonary or neuromuscular causes. While CPAP is commonly prescribed for obstructive sleep apnea, severe obesity increases the likelihood of associated hypoventilation physiology; in outpatient CDI review, this becomes a documentation opportunity to ensure the provider specifies whether the patient has OSA alone versus OSA with OHS/alveolar hypoventilation, because the latter reflects higher clinical complexity and requires clear monitoring/management (e.g., ABGs or bicarbonate trends, symptoms of hypoventilation, adherence, need for BiPAP). Heart failure and pulmonary edema are not implied by CPAP use, and essential hypertension is common in obesity but not the condition most specifically linked to CPAP dependence. Therefore, alveolar hypoventilation is the best supported answer.

Year 2 shows a higher total volume of MDD diagnoses (185,090 vs. 155,501), but the key CDI signal is the shift in coding specificity: “MDD, specified” increases substantially (118,516 vs. 76,318), while “MDD, unspecified” decreases (66,574 vs. 79,193). In outpatient CDI terms, this pattern is consistent with improved documentation quality and code capture—providers are describing the condition with greater clinical detail (episode type, severity, remission status, recurrence, etc.), allowing assignment of more specific ICD codes. When an HCC value (0.299) is associated with MDD, improved capture of qualifying, specific MDD codes supports more accurate risk adjustment. That increases the accuracy of projected resource need and affects future cost benchmarking (and potentially quality/utilization comparisons) because the population’s documented burden of illness is better represented. Therefore, the appropriate inference is increased patients plus increased “specified” use and decreased “unspecified,” with an impact on future benchmarking.

The Relative Factors table shown is a demographic/eligibility-driven component of risk scoring for female beneficiaries, separating patients by setting/status (community vs institutional) and age band. “Institutional” beneficiaries carry higher expected cost because they typically require more resources and support than community patients. In the chart, the institutional relative factor for females age 70–74 is higher than the community factors shown for similar ages and higher than the 90–94 institutional factor displayed. Among the answer choices, option C is the only patient who matches an institutional setting (skilled nursing facility) in the 70–74 age band (72 years). Option D is also institutional, but the table’s 90–94 institutional value is lower than the 70–74 institutional value in this specific chart. Options A and B are community patients, whose relative factors are lower than the institutional values shown. While the listed diagnoses are clinically important and may affect HCC-based risk, the question asks “based on the above chart,” so the highest risk is determined by the chart’s demographic/setting factor—making the 72-year-old institutional patient the highest.

Outpatient CDI follow-up must balance responsiveness with confidentiality and professional standards. The most compliant approach is to communicate query-related information in a setting that protects protected health information and minimizes the risk of incidental disclosure. Discussing the query in a private room with the door closed supports timely clarification while maintaining privacy, avoiding conversations that could be overheard by patients, visitors, or staff who are not involved in the patient’s care. Catching the provider in the hallway is faster but increases privacy risk because clinical details can be overheard, and it may also distract the provider in a high-traffic environment. Leaving a sticky note on the next patient’s chart is inappropriate because it can be seen by others, may be misplaced, and can create compliance and medico-legal concerns (including mixing patients or leaving PHI unsecured). Waiting for the next scheduled meeting may be compliant but does not support a quick response, potentially delaying coding completion and data integrity. Therefore, a private discussion is both the quickest and most compliant option.

In ambulatory CDI chart review, clinical indicators should align with assessment and management captured in the note (problem relevance and MEAT-style support: monitor, evaluate, assess/address, treat). This visit has two strong indicators that warrant medication evaluation. First, dyspnea plus a rapid 10-lb weight increase over two weeks is a classic signal of possible fluid overload in a patient with heart failure, making a loop diuretic such as Lasix clinically relevant to assess (effectiveness, adherence, dose changes, exacerbation risk, and whether HF is stable vs decompensated). Second, the A1c has worsened significantly (9.2 from 7.2), indicating inadequate glycemic control that should prompt review and adjustment of diabetes therapy; insulin such as NovoLog is directly tied to diabetes treatment escalation or optimization. The other medication pairs do not logically match the documented problems and indicators (e.g., appetite stimulant/anemia therapy, immunosuppressant, antidepressant/antihistamine). Therefore, NovoLog and Lasix best reflect what should be evaluated and addressed

A key distinction is that inpatient coding is tightly linked to MS-DRG assignment and inpatient-specific sequencing rules, including selection of the principal diagnosis using the “after study” standard and capture of secondary diagnoses that qualify as complications/comorbidities (CC/MCC) when they meet reporting criteria. This makes diagnosis sequencing and documentation of severity/acuity central to inpatient reimbursement and quality measurement. Outpatient coding does not use MS-DRGs; instead, it typically uses “first-listed” diagnosis concepts for the encounter and assigns ICD-10-CM based on conditions addressed that day, with procedure payment often driven by CPT/HCPCS and, in hospital outpatient departments, packaging/OPPS logic. Therefore, statement A is incorrect (principal diagnosis is not the outpatient focus), C is incorrect (there are meaningful differences), and D is incorrect because outpatient coding absolutely depends on encounter diagnoses being documented and supported. Outpatient CDI education stresses documenting the reason for visit, linking symptoms to confirmed conditions when known, and showing MEAT for chronic conditions so outpatient coding is accurate and defensible.

A high query rate with a strong physician response rate shows the CDI specialist is generating many queries and providers are opening/responding to them. However, a consistently lowagree rateindicates providers frequently select “disagree,” “clinically undetermined,” or otherwise do not validate the query’s suggested clarification. In outpatient CDI program management, that pattern most often reflectsquery quality problems—for example, queries that are not well-supported by encounter-specific clinical indicators, queries that are vague or overly speculative, or queries that do not align with outpatient reportability standards (e.g., prompting for diagnoses not clearly monitored/evaluated/assessed/treated). While leading queries are a compliance concern, the more direct operational inference from “high volume + answered + not agreed with” is that the queries are not clinically compelling or are poorly constructed, resulting in frequent provider non-concurrence. Case complexity alone would not reliably drive low agree rates if the queries were appropriately targeted and evidence-based. Therefore, the most likely interpretation is poor-quality queries requiring coaching on clinical support, clarity, and compliant construction.

For ICD-10-CM injury coding, fracture codes require the correct 7th character to reflect the encounter type and healing status. Because the patient is being seen in the officeaftersurgical treatment (ORIF) and the orthopedist documents the fracture is “healing well without any complication,” this is asubsequent encounter for routine healing, not an initial encounter. Therefore, options A and B are incorrect because they use “initial encounter.” Next, the injury is described as acompound fracture, which is synonymous with anopen fracture. That makes a closed-fracture option inappropriate, eliminating option C. The remaining correct choice is the subsequent-encounter routine-healing option that also identifies the fracture as open. Outpatient CDI principles emphasize ensuring providers document key fracture elements—laterality, anatomic site, open vs closed, and healing status—because these drive compliant code assignment and correct sequencing for follow-up care. While real-world documentation ideally includes Gustilo type specificity, based on the provided choices, the best match is routine healing, subsequent encounter, open fracture.

In ambulatory CDI risk adjustment, the largest RAF impact typically comes from ensuring accurate capture of high-weight, HCC-relevant chronic conditions—especially active malignancies with metastasis. “Metastatic melanoma (followed by oncology)” suggests an ongoing, clinically significant condition, but the wording could represent active metastatic disease, history of metastatic disease, remission, or no current evidence of disease. Because HCC models distinguish active metastatic cancer from history-only status, clarifying thecurrent status(active/under treatment, recurrent, in remission, history) can materially change whether the condition qualifies for risk adjustment and how the patient’s expected cost is benchmarked. By comparison, adding BMI (when morbid obesity is already documented) generally does not increase HCC capture, and fracture sequelae typically does not drive HCC risk scoring in the same way. Bipolar disorder may map to an HCC, but its relative impact is generally lower than metastatic cancer, making melanoma status the highest-value clarification.

When documentation states “metastatic uterine cancer,” the most important missing element for complete, accurate outpatient coding iswhere the cancer has metastasized(the secondary site[s]). In ambulatory CDI, identifying secondary sites best clarifies the full scope of disease being monitored and treated because metastatic disease coding relies on documenting both the primary malignancy and the specific metastatic location(s) (e.g., lung, liver, bone, peritoneum, lymph nodes). This supports correct severity representation, risk capture, treatment intent, and medical necessity for ongoing chemotherapy follow-up. While tumor morphology can be clinically relevant, it is usually established earlier in the diagnostic pathway and does not, by itself, define current metastatic burden. Likewise, reviewing labs or MRI results may provide supportive indicators, but they do not replace provider documentation of theconfirmed metastatic sitesbeing managed. A compliant query focused on secondary sites prompts the provider to document the current metastatic disease status (active, responding, progressing) and specific locations, which most directly identifies the conditions under treatment.

The documentation shows a patient with advanced COPD (GOLD stage 3) who now requires an increase in home oxygen to 3 liters, along with escalation of respiratory therapies (home nebulizers and systemic steroids). In outpatient CDI, an increased or ongoing home oxygen requirement is a strong clinical indicator that the provider may be managingchronic respiratory failure(or chronic hypoxemic respiratory failure), which is more clinically meaningful than simply documenting oxygen use as a status. “Oxygen dependence” is a status code and does not fully describe the underlying physiologic impairment driving the need for oxygen; chronic respiratory failure captures the severity and ongoing nature of the condition and better reflects risk, complexity, and medical necessity for durable oxygen therapy. Querying for pneumonia organism specificity is not as relevant in a follow-up visit unless pneumonia is still being actively treated and the organism is known. Querying COPD acuity (e.g., exacerbation) may be appropriate, but the most significant clarification prompted by increased home O2 is whether chronic respiratory failure is present and being managed.

RAF (Risk Adjustment Factor) is a population risk stratification metric used in risk adjustment models to estimate expected healthcare resource utilization for an individual beneficiary relative to an average patient. In outpatient CDI, RAF is driven by a combination of demographic elements (such as age/sex and eligibility/status factors) and—critically—documented, coded conditions that map to risk categories (e.g., HCCs). The intent is not to “predict the provider’s reimbursement” for the current year in a direct, visit-by-visit sense; rather, RAF contributes to actuarial projections of expected cost and supports payment benchmarking and budget setting in value-based arrangements (e.g., Medicare Advantage and certain shared savings models). RAF is also not based only on demographics (eliminating option B) and it does not determine reimbursement for each individual office visit (eliminating option D). ACDIS outpatient CDI emphasizes that accurate, specific documentation and coding of active, clinically supported conditions improves the accuracy of RAF, which in turn better aligns projected costs and comparisons across attributed populations.

A Stage 4 pressure ulcer (pressure injury) is characterized byfull-thickness tissue losswithextensive destruction, tissue necrosis, or damage to muscle, bone, or supporting structures. The key phrase in the question—“necrosis of soft tissue through the underlying muscle”—signals a depth of injury that extends beyond the subcutaneous tissue and involves muscle, which is consistent with Stage 4. By comparison, Stage 2 involves partial-thickness skin loss with exposed dermis (no necrosis through deeper structures). Stage 3 involves full-thickness skin loss where adipose may be visible, butmuscle, tendon, or bone are not exposed; undermining and tunneling may occur, yet the defining line is that it does not extend to muscle/bone involvement. “Stage 5” is not part of standard pressure ulcer staging used in coding and documentation. Outpatient CDI practice emphasizes documenting the exact stage, anatomic location, laterality when applicable, and whether the ulcer is healing or complicated (infection/osteomyelitis) because stage drives specificity, severity capture, and appropriate care planning documentation.

In obstetric and postpartum coding, the most important clarification is thetype/timingof hypertension because ICD-10-CM has distinct categories for chronic (pre-existing) hypertension, gestational hypertension, and hypertensive disorders that persist into or present during the postpartum period. At 6 weeks postpartum with elevated readings (including a systolic of 160) and headache, the documentation “hypertension” is not specific enough to determine whether this represents chronic hypertension that predates pregnancy, gestational hypertension that has not resolved, or another pregnancy-related hypertensive disorder requiring different obstetric coding and follow-up. ACDIS outpatient CDI guidance prioritizes queries that resolve coding-impactful ambiguity using clinically supported options without leading the provider. While postpartum preeclampsia could be a clinical consideration, the note does not provide key supporting elements (e.g., proteinuria or other definitive severe-feature criteria), so jumping directly to preeclampsia/eclampsia is less appropriate than clarifying onset and relationship to pregnancy. Linking hypertension to smoking is not a standard required linkage for diagnosis coding, and “hypertensive crisis” is not supported by the documentation provided.

Provider engagement in an outpatient CDI program is best reflected by measures that show the provider is actively interacting with CDI processes and improving documentation behaviors in real time.Query response ratesdirectly indicate whether the provider is reading and responding to CDI clarifications promptly and consistently, which is a fundamental engagement behavior and a key operational driver of documentation accuracy.Problem list updatesfurther demonstrate sustained engagement because they reflect the provider’s willingness to maintain an accurate, current list of active conditions (adding validated diagnoses, removing resolved problems, and updating specificity such as stage, severity, or laterality). Together, these two metrics show both immediate participation (responding to queries) and longer-term adoption of documentation best practices (maintaining the problem list). In contrast,RAF scoresandRAF capture ratesare influenced by patient complexity, payer mix, and coding capture processes, and may improve even without meaningful provider participation.MIPS scoresreflect broader quality program performance and are not specific to CDI-provider interaction. Therefore, query responsiveness plus problem list maintenance most directly measures engagement with outpatient CDI.

For outpatient Evaluation and Management (E/M) services, “medical necessity” is ultimately judged against Medicare coverage policy, which is established through National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs). NCDs set nationwide rules for when specific services are considered reasonable and necessary, while LCDs are developed by Medicare Administrative Contractors to define coverage expectations within their jurisdictions, including indications, frequency limits, required documentation elements, and diagnosis-to-service relationships. Outpatient CDI and coding education emphasizes that correct E/M code selection and documentation must support not only the level of service (MDM/time) but also why the service was needed based on the patient’s condition and the payer’s coverage criteria. Specialty society recommendations and AMA/AHA guidance can inform clinical practice and coding conventions, but they do not define Medicare coverage requirements. Likewise, AHIMA provides professional guidance but does not set payer medical necessity policy. Therefore, the most accurate source defining medical necessity criteria for billing compliance is NCDs and LCDs.

RVUs are the foundation of Medicare’s physician fee schedule methodology and are built from three core components: physician work (wRVU), practice expense (peRVU), and malpractice (mpRVU). The malpractice expense RVU reflects the relative professional liability insurance cost associated with providing a service and is a defined element of the RVU calculation used to determine payment rates. In outpatient documentation and CDI education, it’s important to distinguish what drivescode selectionversus what is apayment calculation ingredient. Time with the patient and medical decision making influence E/M code selection under current E/M rules, but they are not standalone components of the RVU formula itself—they contribute indirectly by determining which CPT code is billed, and each CPT code has preassigned RVUs. Physician specialty type also is not a direct RVU component, even though specialty patterns can affect typical service mix and overall wRVU productivity. Therefore, among the options, malpractice expense is the explicit RVU component used in the calculation.

In ICD-10-CM diabetes coding (as reinforced in outpatient CDI education), some diabetes manifestations are fully captured by a single diabetes “combination” code, while others require a diabetes complication codeplus an additional codeto identify the specific manifestation. Diabeticnephropathyand many forms of diabeticretinopathyare commonly represented by diabetes combination codes that already describe the manifestation with built-in specificity options (e.g., diabetes with nephropathy; diabetes with retinopathy with/without macular edema and severity).Osteomyelitis, however, is typically captured using a diabetes code such as “diabetes with other specified complication” (e.g., E11.69) to establish the linkage to diabetesandan additional code from the osteomyelitis category (e.g., M86.-) to specify the site, acuity, and type of osteomyelitis. From a chart review standpoint, CDI often queries to confirm the causal relationship (“due to diabetes”) and to ensure the osteomyelitis details (site, acute vs chronic) are documented so both codes can be assigned accurately and compliantly.

The Medicare Shared Savings Program (MSSP) is designed to move reimbursement away from pure volume-based payment and toward value by rewarding organizations that reduce the total cost of care for an assigned Medicare population while meeting defined quality performance requirements. In MSSP, eligible provider groups participate as Accountable Care Organizations (ACOs) and are compared against a financial benchmark. If the ACO’s actual spending comes in below the benchmark and quality standards are achieved, the ACO can earn a portion of the savings—hence “shared savings.” Outpatient CDI supports MSSP success by ensuring documentation accurately reflects patients’ true disease burden (supporting appropriate risk adjustment for benchmarking), and that conditions addressed during visits are clearly documented as evaluated/managed to support reliable coding and quality measurement. While improving transitions of care may be a strategy that helps achieve savings and quality goals, it is not the core purpose of the program itself. Likewise, MSSP is not intended to increase fee schedule payments or simply optimize risk scores; the primary aim is participating in value-based care and sharing in savings when performance supports it.

ACOs commonly focus on strengthening documentation and coding of clinically relevant chronic conditions because many quality and utilization comparisons—including readmission-related performance assessments—are influenced by patient complexity and risk adjustment. When chronic diseases and their specificity (e.g., stage, severity, manifestations) are under-documented, attributed patients can appear “healthier” on paper than they truly are, which can worsen an organization’s apparent readmission performance when outcomes are compared to an expected benchmark. Provider education that reinforces documenting active conditions that are monitored, evaluated, assessed/addressed, or treated helps ensure an accurate picture of acuity and comorbidity burden. This improves the integrity of risk adjustment inputs and supports fairer benchmarking, while also strengthening medical necessity and continuity-of-care communication across settings. The other choices represent either noncompliant behavior (avoiding condition reporting), poor documentation practice (promoting unspecified codes), or operational maneuvering that may be perceived as gaming rather than a sustainable quality strategy. Therefore, educating providers to capture chronic conditions accurately is the best and most commonly used improvement approach.